Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen‐induced Th2 responses, airway inflammation and airway hyper‐reactivity in mice

Abstract

These data indicate that R-848 effectively inhibits allergen-induced airway inflammation and hyper-reactivity by modulation of increased Th2-immune responses.